Gestational diabetes is glucose intolerance that develops during pregnancy, characterized by insulin resistance and hyperglycemia. It represents an extreme form of the physiological insulin resistance that normally occurs in pregnancy to prioritize fetal glucose supply.
During pregnancy, placental hormones (human placental lactogen, cortisol, progesterone) induce maternal insulin resistance to ensure continuous glucose availability for the fetus. In gestational diabetes, this adaptive insulin resistance becomes excessive, leading to hyperglycemia. The resulting hyperinsulinemia drives excessive fetal growth (macrosomia), programming the baby for high-nutrient environment. This creates a metabolic mismatch if the postnatal environment is nutrient-restricted.
Gestational diabetes programs offspring for insulin resistance, obesity, and metabolic syndrome through developmental mismatch. Large babies (>4000g) born to GDM mothers are metabolically programmed for high nutrient availability but often face postnatal nutrient restriction, creating 'disturbing' developmental outcomes. In cPNI assessment, maternal gestational diabetes is a critical marker for patient's developmental programming and metabolic phenotype, helping predict insulin resistance risk and therapeutic needs.
- Represents excessive maternal insulin resistance during pregnancy
- Causes fetal hyperinsulinemia and macrosomia (birth weight >4000g)
- Programs offspring for insulin resistance and metabolic syndrome
- Creates developmental mismatch if postnatal nutrition is restricted
- Large babies from GDM mothers are 'disturbing' — maladaptively programmed
- Maternal thyroid status during pregnancy affects metabolic programming
- Asking if mother felt 'hot or cold during pregnancy' assesses thyroid function proxy
- GDM is marker of adverse prenatal conditions affecting lifelong metabolism
- insulin resistance — gestational diabetes is extreme pregnancy insulin resistance affecting maternal-fetal metabolism
- macrosomia — GDM-induced hyperinsulinemia causes excessive fetal growth and large birth weight
- developmental programming — GDM programs offspring metabolism for high-nutrient environment
- Metabolic syndrome — offspring of GDM pregnancies have increased risk of metabolic syndrome
- Epigenetics — GDM creates epigenetic programming affecting offspring metabolic phenotype
- Pregnancy — normal pregnancy insulin resistance becomes pathological in GDM
- placenta — placental hormones drive insulin resistance that becomes excessive in GDM
- cortisol — elevated cortisol contributes to insulin resistance in pregnancy and GDM
- thyroid — maternal thyroid dysfunction during pregnancy increases GDM risk
- Type 2 Diabetes — GDM increases maternal risk of developing Type 2 diabetes later
- obesity — GDM-exposed offspring have increased obesity risk through metabolic programming
- birth weight — GDM typically causes high birth weight through fetal hyperinsulinemia
- low birth weight — paradoxically, some GDM with poor glycemic control can cause placental insufficiency
- Mismatch Disease — GDM creates prenatal-postnatal nutritional mismatch affecting lifelong health
- Intrauterine programming — GDM is a key form of adverse intrauterine programming
- liver dysfunction — maternal hepatic insulin resistance contributes to GDM pathophysiology
- chronic hepatitis — chronic liver disease increases GDM risk through metabolic dysfunction
- Metabolic flexibility — GDM-programmed offspring often have reduced metabolic flexibility
- glucose metabolism — GDM fundamentally alters maternal and fetal glucose handling
- hunter-farmer — GDM phenotype affects offspring hunter vs farmer metabolic classification
- Module 2
- Module 5
- Module 8